Mitigating Risks of Compounded Drugs Through Surveillance FDA Can BPC 157 Help with Erectile Dysfunction? FDA Peptide Regulation and HHS Policy Holt Law FDA to weigh easing limits on unproven peptides The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York